About 17 Trademarks found that are owned by Dendreon PharmaceutIcals LLC

Color is not claimed as a feature of the mark.

research and development of pharmaceutical products for others

The mark consists of the term "Dendreon" having an upper case "D" and lower case "endreon" in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters "e", "o" and "n" the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the "e" slightly upward to the right side of the "o"; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the "o" slightly upward to the right side of the "n" resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part.

pharmaceuticals for use in the treatment of cancer

Pharmaceutical preparations for use in the treatment of cancer

The mark consists of the term "Dendreon" having a capital "D" and lowercase "endreon" in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters "e," "o," and "n," the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the "e" slightly upward to the right side of the "o"; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the "o" slightly upward to the right side of the "n," resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part.

Antibacterial pharmaceuticals; Antibacterial substances for medical purposes; Cells for medical or clinical use; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Intravenous bags sold filled with sipuleucel-T; Pharmaceutical preparations for the treatment and prevention of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of cancer; Pharmaceuticals, namely, anti-infectives; Therapeutic pharmaceutical for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Living cells for medical use; Pharmaceutical preparations for the treatment of infectious diseases

The mark consists of the term "Dendreon" having a capital "D" and lowercase "endreon" in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters "e," "o," and "n," the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the "e" slightly upward to the right side of the "o"; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the "o" slightly upward to the right side of the "n," resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part; and a tag line portion below the term "Dendreon" consisting of the phrase "Targeting Cancer, Transforming Lives" in title case.

The mark consists of the term "Dendreon" having an upper case "D" and lower case "endreon" in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters "e", "o" and "n" the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the "e" slightly upward to the right side of the "o"; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the "o" slightly upward to the right side of the "n" resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part; and a tag line portion below the term "Dendreon" consisting of the phrase "Targeting Cancer, Transforming Lives" in title case.

kit for cell separation consisting primarily of density gradient solutions and a centrifugation tube or a syringe with a modified internal constriction for medical and clinical applications

kit for cell separation consisting primarily of density gradient solutions and a centrifugation tube or a syringe with a modified internal constriction for scientific and research applications